Xgeva 120 MG in 1.7 ML Injection
- RxCUI
- 1046402
- RxNorm name
- Xgeva 120 MG in 1.7 ML Injection
- Display name
- Xgeva 120 MG in 1.7 ML Injection
- Full name
- Xgeva 120 MG in 1.7 ML Injection
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:01
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125320 | Prolia | denosumab | 351(a) | Rx | 2026-07-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| XGEVA | DENOSUMAB | Amgen, Inc | 628f0998-1206-4001-aeee-18133aa9f3bf | 2026-06-23 | Warnings, Adverse reactions | 1046402 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 628f0998-1206-4001-aeee-18133aa9f3bf | Xgeva 120 MG in 1.7 ML Injection [PSN] · 1.7 ML denosumab 70 MG/ML Injection [Xgeva] [SBD] · Xgeva 120 MG per 1.7 ML Injection [SY] | 3 | 176 | These highlights do not include all the information needed to use X GEVA ® safely and effectively. See full prescribing information for X GEVA . Xgeva ( denosumab ) i njection , for subcutaneous u se Initial U.S. Approval: 2010 | 20250916 |